Administrative Supplement to Award "Circadian regulation of vascular aging"
“血管老化的昼夜节律调节”奖行政补充
基本信息
- 批准号:10283788
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-18 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:ARNTL geneAblationAdministrative SupplementAgingAlzheimer&aposs DiseaseAortaArteriesAtherosclerosisAwardBlood VesselsBlood flowBrainBrain regionCardiovascular DiseasesCardiovascular systemCell physiologyCellsCerebrovascular CirculationCerebrovascular DisordersCerebrovascular systemCerebrumChIP-seqClinicalClinical ResearchClock proteinComplementDataDementiaDevelopmentDiseaseEventFoundationsFunctional disorderFundingFutureHomeostasisHypertensionImageImpaired cognitionImpairmentIncidenceInfarctionKnowledgeLeadLesionLinkLongevityMediatingMidbrain structureMolecularMolecular ProfilingMolecular StructureMusNational Heart, Lung, and Blood InstituteNutrientOxygenParentsPathologyPeripheral arterial diseasePhysiologic pulsePlayPopulationPreventionPrevention strategyProteinsPublic HealthRegulationReportingRisk FactorsRoleScienceSignal TransductionSmooth Muscle MyocytesStrokeStructureSystems BiologyTestingTimeVascular DementiaVascular DiseasesVascular Smooth MuscleVascular SystemVascular calcificationage relatedarterial stiffnesscalcificationcell typecerebral arterycerebrovascularcircadiancircadian pacemakercircadian regulationclinical applicationcognitive functiondesignepidemiology studyexperimental studyfield studyimprovedin vivoinsightmeetingsmouse modelnovelnovel strategiesosteogenicrelating to nervous systemsingle-cell RNA sequencingtranscription factortranscriptome sequencingtranscriptomicsvascular cognitive impairment and dementiawater maze
项目摘要
Abstract: Aging is the major risk factor for a variety of diseases, particularly Alzheimer's dementia (AD) and
cardiovascular diseases. Vascular contribution to cognitive impairment and dementia (VCID) is the second most
common cause of dementia after AD. Vascular damage in the mid-brain regions causes progressive cognitive
impairment similar to that of AD; and vascular dementia often coexists with Alzheimer's plaques. Therefore,
better understanding of VCID may provide new solutions that improve prevention and management of VCID and
AD. Cerebrovascular dysfunction, featuring brain vascular lesions and infarctions, limits blood flow and reduces
oxygen and nutrient supply to the brain which results in impairment of brain activity and cognitive function.
Vascular aging not only impairs normal vascular contraction and compliance but also increases the incidence of
cardiovascular disease, including hypertension, stroke and peripheral artery disease. Clinical, epidemiological
and experimental studies have demonstrated that multiple vascular diseases, such as stroke, hypertension,
atherosclerosis and arterial stiffness, are associated with VCID and accelerate the progression of cognitive
impairment and dementia. Our current NHLBI-funded Parent proposal on “Circadian regulator of vascular
aging” (5R01HL146103) aims to uncover the previously unknown function of the master osteogenic
transcriptional factor, Runx2, in regulating vascular smooth muscle cell (VSMC) function during the development
of vascular aging. The Parent proposal focuses on the study of arterial stiffness and calcification in the large
aortic arteries; and attempts to define the previously unknown regulation of Runx2 by circadian clock-mediated
protein O-GlcNAcylation. Studies in the Parent proposal identified increased Runx2 expression in mouse aortas
in an age-dependent manner, which was associated with increased pulse wave velocity (PWV), an indicator for
arterial stiffness and a predictor for future cardiovascular events. Preliminary studies determined that Runx2
deficiency in SMC inhibited arterial stiffness, and improved cerebral blood flow. Furthermore, mice with SMC-
specific Runx2 deletion took less time in finding objects in the water maze test and moved faster in the open field
test, suggesting improved cognitive function. These exciting observations suggest a new role played by Runx2
in SMC in regulating cerebral arterial blood flow and cognitive function. Thus, this Supplement application will
take advantage of the two new SMC-specific deletion of BMAL1 (clock dysfunction) and OGT (O-GlcNAcylation
ablation) mouse models generated from the Parent R01 to uncover the novel function of the BMAL1/OGT/Runx2
signaling cascade in regulating cerebral vascular function and VCID. Furthermore, we will dissect the distinct
and overlapping molecular determinates in two vascular systems, aortic and cerebral, using unbiased system
biology approaches, which may lead to identification of new signaling cascades and signature cell populations
that uniquely regulate cerebral vascular function and VCID; and provide new insights into novel strategies for
prevention of age-related vascular disorders, and improving public health and lifespan.
翻译后摘要:老化是各种疾病的主要危险因素,特别是阿尔茨海默氏痴呆症(AD),
心血管疾病血管对认知障碍和痴呆(VCID)的贡献是第二大
AD后痴呆的常见原因。中脑区域的血管损伤会导致渐进性认知障碍
血管性痴呆常与阿尔茨海默病斑块共存。因此,我们认为,
更好地了解VCID可以提供新的解决方案,改善VCID的预防和管理,
AD.脑血管功能障碍,以脑血管病变和梗死为特征,限制血液流动,
氧气和营养供应到大脑,导致大脑活动和认知功能受损。
血管老化不仅损害正常的血管收缩和顺应性,而且还增加了
心血管疾病,包括高血压、中风和外周动脉疾病。临床、流行病学
实验研究表明,多种血管疾病,如中风,高血压,
动脉粥样硬化和动脉硬化与VCID相关,并加速认知功能障碍的进展。
损伤和痴呆。我们目前NHLBI资助的关于“血管的昼夜节律调节器”的家长提案
老化”(5 R 01 HL 146103)旨在揭示以前未知的主成骨细胞的功能,
转录因子Runx 2在发育过程中调节血管平滑肌细胞(VSMC)功能
血管老化的迹象Parent提案的重点是研究大动脉硬化和钙化,
主动脉;并试图定义以前未知的调节Runx 2的昼夜节律钟介导的,
蛋白质O-GlcNAc化。亲本提案中的研究确定了小鼠睾丸中Runx 2表达的增加
以年龄依赖的方式,这与脉搏波速度(PWV)增加有关,PWV是
动脉硬化和未来心血管事件的预测因子。初步研究确定Runx 2
SMC缺乏抑制动脉硬化,改善脑血流量。此外,SMC-
特异性Runx 2缺失在水迷宫测试中寻找物体所需的时间更短,在开阔视野中移动更快
测试,表明认知功能改善。这些令人兴奋的观察表明Runx 2扮演了新角色
SMC在调节脑动脉血流和认知功能中的作用。因此,本补充申请将
利用两种新的SMC特异性缺失BMAL 1(生物钟功能障碍)和OGT(O-GlcNAcylation
消融)小鼠模型,以揭示BMAL 1/OGT/Runx 2的新功能
信号级联调节脑血管功能和VCID。此外,我们将剖析不同的
和重叠的分子决定因素在两个血管系统,主动脉和脑,使用无偏系统,
生物学方法,这可能导致识别新的信号级联和签名细胞群
其独特地调节脑血管功能和VCID;并提供了对新策略的新见解,
预防与年龄有关的血管疾病,改善公众健康和寿命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN C CHATHAM其他文献
JOHN C CHATHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN C CHATHAM', 18)}}的其他基金
STIM1 and its role in regulating cardiac metabolism
STIM1及其在心脏代谢中的调节作用
- 批准号:
10371868 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology
蛋白O-连接的N-乙酰氨基葡萄糖在调节心脏生理学中的作用
- 批准号:
10213829 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
STIM1 and its role in regulating cardiac metabolism
STIM1及其在心脏代谢中的调节作用
- 批准号:
10592268 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Rapid modulation of hippocampal GABAergic Inhibition by O-GlcNAcylation
O-GlcNAc 酰化快速调节海马 GABA 能抑制
- 批准号:
9765783 - 财政年份:2019
- 资助金额:
$ 37.13万 - 项目类别:
Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes
糖尿病期间心脏自噬的异常昼夜节律调节
- 批准号:
10288158 - 财政年份:2018
- 资助金额:
$ 37.13万 - 项目类别:
Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes
糖尿病期间心脏自噬的异常昼夜节律调节
- 批准号:
9543678 - 财政年份:2018
- 资助金额:
$ 37.13万 - 项目类别:
Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes
糖尿病期间心脏自噬的异常昼夜节律调节
- 批准号:
10078980 - 财政年份:2018
- 资助金额:
$ 37.13万 - 项目类别:
Disruption of the Clock O-GlcNAc axis in diabetic cardiomyopathy
糖尿病心肌病中时钟 O-GlcNAc 轴的破坏
- 批准号:
8814019 - 财政年份:2014
- 资助金额:
$ 37.13万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Standard Grant














{{item.name}}会员




